ARCHIVES

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

This article is from The Cancer Letter archive.

Vol. 35 No. 15 | April 17, 2009

Download PDF Visit The Full Archive

Related Articles

“Don’t Judge Me On a Snapshot In Time,” Broder Says In Responding To Criticisms By Cancer Centers

July 7, 1989

AACR Meeting: Celebrex Studies Show Benign Polyp Reduction, Point To Challenges In Biomarker Validation.

April 14, 2006

U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention

April 29, 2005

NCAB Discussion Of Working Group Report

February 28, 2003

AMA, ACOS, VA Express Interest In Trials; NCI, DCT Board Cool

March 3, 1989

Proceedings Initiated Against Two Physicians At Dana-Farber

April 7, 1995